Nathalie Albert, MD, and Matthias Preusser, MD engage in an interactive discussion about the primary challenges in neuroimaging for glioblastoma patients and provide an overview of the disease.
Sac-TMT improved OS vs treatment of physician’s choice in pretreated gastroesophageal adenocarcinoma, but TroFuse-015 missed its PFS secondary end point.